Thanks for the replies. Realistically, what sort of takeup do you expect in the UK and Australia once OncoSil is approved for use? Outside of what the company is saying, is there much in the way of indications that the medical professionals who matter are ready to start using OncoSil?
OSL Price at posting:
9.6¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)